Hydrobromides
Medchemexpress LLC Pifithrin-β hydrobromide | 511296-88-1 | MFCD02683960 | >=98.0% | 349.29 g/mol | C16H17BrN2S | 10 MG
Pifithrin-β hydrobromide is a small-molecule inhibitor of the p53 pathway supplied as the hydrobromide salt. It reversibly blocks p53 transcriptional activity (reported IC50 = 23 μM) and is used as a research tool in cellular and biochemical studies of apoptosis and ferroptosis. Chemical formula C16H17BrN2S; molecular weight 349.29 g/mol; CAS 511296-88-1.
- Reversible p53 inhibitor with reported IC50 of 23 μM.
- Hydrobromide salt for improved solubility and handling.
- Reported high purity (≥98% by HPLC) in supplier listings.
- Suitable for cellular and biochemical assays studying apoptosis and ferroptosis.
- Store sealed at 4 °C as a solid; in solution store at -80 °C for long-term stability.
Medchemexpress LLC Burixafor hydrobromide | 1191450-19-7 | 98.0% | 769.01 | 100 MG
Burixafor (TG-0054) hydrobromide is a potent CXCR4 antagonist with a pIC50 of 7.4. It inhibits the binding of CXCL12 to CXCR4, antagonizes CXCL12-induced recruitment of Gαᵢ and β-arrestin2, and blocks the downstream Gαᵢ-mediated inhibitory effect on cAMP signal transduction. Burixafor hydrobromide mobilizes CD34+ hematopoietic stem/progenitor cells (HSPC) from the bone marrow to the peripheral blood and can be used for research on autologous hematopoietic stem cell transplantation (ASCT).
- Potent CXCR4 antagonist with a pIC50 of 7.4
- Inhibits CXCL12 binding to CXCR4
- Antagonizes CXCL12-induced recruitment of Gαᵢ and β-arrestin2
- Blocks downstream Gαᵢ-mediated inhibitory effect on cAMP signal transduction
- Mobilizes CD34+ hematopoietic stem/progenitor cells (HSPC) from bone marrow to peripheral blood
- Can be used for research on autologous hematopoietic stem cell transplantation (ASCT)
Medchemexpress LLC 8-hydroxy-DPAT hydrobromide | 76135-31-4 | MFCD00055158 | 99.9% | 328.29 | C16H26BrNO | 10 MG
8-hydroxy-DPAT hydrobromide is the hydrobromide salt of 8-hydroxy-2-dipropylaminotetralin, a potent and selective agonist of the serotonin 5-HT1A receptor used in neuropharmacology research. Supplied as a high-purity solid, it is suitable for in vitro and in vivo studies and is provided with analytical documentation.
- Potent, selective 5-HT1A receptor agonist (pIC50 ~8.19).
- Hydrobromide salt for improved stability and handling.
- High purity (>99.8%) suitable for research applications.
- Available as a solid; common pack size 10 mg.
- Provided with COA, 1H NMR, and LC-MS documentation.
- Molecular formula C16H26BrNO; molecular weight 328.29.
eMolecules Ambeed 3-Bromopiperidine-2 6-dione 250mg 506392068 A875928 0 000 62595-74-8 MFCD11053059 192 012 C5H6BrNO2
Ambeed 3-Bromopiperidine-2 6-dione 250mg 506392068 A875928 0 000 62595-74-8 MFCD11053059 192 012 C5H6BrNO2
Medchemexpress LLC Halofuginone hydrobromide | 64924-67-0 | 495.59 | 1 MG
Halofuginone hydrobromide | 64924-67-0 | 495.59 | 1 MG
eMolecules Aniline hydrobromide | 542-11-0 | MFCD00035465 | 1g
Oakwood Chemicals | Aniline hydrobromide | 1g | 480148775 | 098809 | | 542-11-0 | MFCD00035465 | 174.041 | C6H8BrN
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool
Medchemexpress LLC Rociletinib hydrobromide | 1446700-26-0 | MFCD28386290 | 98.0% | 636.46 g/mol | C27H29BrF3N7O3 | 10 MG
Rociletinib hydrobromide is the hydrobromide salt of rociletinib, an orally active kinase inhibitor selective for mutant forms of the epidermal growth factor receptor (EGFR) including T790M. It is supplied as a solid research reagent for biochemical, cellular, and analytical studies.
- Hydrobromide salt of rociletinib.
- Selective inhibitor of mutant EGFR, including T790M.
- Intended for research and analytical applications.
- Purity 98.04% (HPLC).
- Molecular weight 636.46 g/mol.
- CAS number 1446700-26-0.
- Store sealed, away from moisture; in solvent: -80°C (6 months) or -20°C (1 month).
Medchemexpress LLC Homatropine Bromide | 51-56-9 | 99.9% | 1 ML
Homatropine Bromide is an orally active muscarinic acetylcholine receptor antagonist. It functions as an anticholinergic agent and is intended for research applications only. This product is provided as a 10 mM solution in DMSO.
- Orally active muscarinic acetylcholine receptor antagonist
- Functions as an anticholinergic agent
- Provided as a 10 mM solution in DMSO
- Purity of 99.9%
- Suitable for research applications
Medchemexpress LLC SCH-202676 (hydrobromide) | 265980-25-4 | 96.8% | 348.26 | 1 ML
SCH-202676 hydrobromide is an allosteric modulator of G protein-coupled receptors (GPCRs) and adenosine receptor (AR). It demonstrates antiviral activity and inhibits 3CLpro in a time-dependent manner with an IC50 value of 0.655 μM.
- Purity: 96.81%
- Appearance: Solid
- Color: White to off-white
- Solubility: DMSO: 10 mg/mL
Medchemexpress LLC Halofuginone hydrobromide | 64924-67-0 | 495.59 | 50 MG
Halofuginone hydrobromide (RU-19110) is a Febrifugine derivative that acts as a competitive prolyl-tRNA synthetase inhibitor. It is a specific inhibitor of type-I collagen synthesis and attenuates osteoarthritis (OA) by inhibiting TGF-β activity. This compound exhibits various biological effects, including anti-malarial, anti-inflammatory, anti-cancer, and anti-fibrosis activities. It also functions as a potent pulmonary vasodilator.
- Competitive prolyl-tRNA synthetase inhibitor.
- Inhibits type-I collagen synthesis.
- Attenuates osteoarthritis by inhibiting TGF-β activity.
- Potent pulmonary vasodilator, activating Kv channels and blocking Ca2+ channels.
- Exhibits anti-malarial, anti-inflammatory, anti-cancer, and anti-fibrosis effects.
- Decreases NRF2 protein levels in tumors.
- Partially reverses established pulmonary hypertension.
Ambeed 2-BROMOMETHYL PYRIDINE HYDROB
2-(Bromomethyl)pyridine hydrobromide-5 gramsCAS No.: 31106-82-8Ambeed
Medchemexpress LLC SCH-202676 hydrobromide | 265980-25-4 | 96.81% | 348.26 | 100 MG
SCH-202676 hydrobromide is an allosteric modulator of G protein-coupled receptors (GPCRs) and adenosine receptor (AR). It exhibits antiviral activity and inhibits 3CLpro in a time-dependent manner with an IC50 value of 0.655 μM.
- Allosteric modulator of G protein-coupled receptors and adenosine receptor.
- Exhibits antiviral activity.
- Inhibits 3CLpro in a time-dependent manner.
- IC50 value of 0.655 μM.